#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Narcolepsy Ureteric cancer Adenomatous polyposis coli Glioblastoma KBG syndrome Arteriosclerosis Hepatocellular carcinoma Frontotemporal dementia Retinopathy proliferative Encephalopathy neonatal Congenital nephrogenic diabetes insipidus Lymphoma Small intestine adenocarcinoma Cystic fibrosis respiratory infection suppression Arrhythmogenic right ventricular dysplasia More trials…

    Learn about Rare Diseases

    Acute respiratory distress syndrome – Diagnostics Angelman’s syndrome Splenic marginal zone lymphoma – Trials in Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information Mucous membrane pemphigoid – Life with Disease Focal segmental glomerulosclerosis – Treatment Congenital generalised lipodystrophy – Trials in Disease Primary biliary cholangitis – Life with Disease Antithrombin III deficiency – Treatment Toxic epidermal necrolysis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Csm-Gw Nitrofurantoin Gsk4532990A Carbamazepine Ipatasertib Rugonersen Trandolapril ADS-019 Aspergillus Fumigatus H2-Receptor Antagonist Mercaptopurine Selatogrel FLUCLOXACILLIN SODIUM D,L-Lysine Acetylsalicylate Soya-Bean Oil Refined Venlafaxine GSKVX000000048111 Inupadenant Adezunap Filgrastim More therapies…

    Learn about Your Condition

    Ehlers-Danlos syndrome Erectile dysfunction Pulmonary vascular disorder Neuromuscular scoliosis Triple negative breast cancer Migraine with aura Endometrial cancer metastatic Spinal cord injury cervical Pemphigus Cold urticaria Eye inflammation Pancoast's tumour Bladder cancer recurrent Crohn's disease Post procedural oedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

United Kingdom

  • Study of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Medulloblastoma
    Investigated Drugs:
    • Lomustine
    • Thiotepa
    • Carboplatin
    Austria Belgium Czechia Denmark Finland Germany +4

  • Study of Atropine Sulfate eye drops (0.

    Not recruiting

    3 1
    Investigated Diseases:
    • Myopia
    Investigated Drugs:
    • Atropine Sulfate
    Hungary Ireland Poland Slovakia Spain

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Lomustine Thiotepa Carboplatin Cisplatin Cyclophosphamide Temozolomide Vincristine Sulfate Atropine Sulfate Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Medulloblastoma Myopia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!